Cited by 2,447Genetic Associations and EpidemiologyGenetic Mapping and Diversity in Plants and AnimalsGenetics and Physical Performance

A comprehensive 1000 Genomes–based genome-wide association meta-analysis of coronary artery disease

Open access
the CARDIoGRAMplusC4D Consortium·2015·Nature Genetics

Abstract

Existing knowledge of genetic variants affecting risk of coronary artery disease (CAD) is largely based on genome-wide association study (GWAS) analysis of common SNPs. Leveraging phased haplotypes from the 1000 Genomes Project, we report a GWAS meta-analysis of ∼185,000 CAD cases and controls, interrogating 6.7 million common (minor allele frequency (MAF) > 0.05) and 2.7 million low-frequency (0.005 < MAF < 0.05) variants. In addition to confirming most known CAD-associated loci, we identified ten new loci (eight additive and two recessive) that contain candidate causal genes newly implicating biological processes in vessel walls. We observed intralocus allelic heterogeneity but little evidence of low-frequency variants with larger effects and no evidence of synthetic association. Our analysis provides a comprehensive survey of the fine genetic architecture of CAD, showing that genetic susceptibility to this common disease is largely determined by common SNPs of small effect size.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ng.3396

Cites

84 of 84 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • GWAS have identified genetic loci associated with many physical diseases, such as obesity, type 2 diabetes mellitus, and heart disease.

    “as well as with many physical diseases, such as obesity186, type 2 diabetes mellitus187, and heart disease188.”
  • The FGF5 locus has been linked to cardiovascular conditions in previous GWASs.

    “The FGF5 locus has been linked to cardiovascular conditions in previous GWASs67,75.”

    From Genetic determinants of plasma protein levels in the Estonian population (2024) · cites this paper as [75]

    The Scanning for additive associations section discusses previously reported coronary artery disease loci, but the passages found do not identify FGF5 among them. Searches for “FGF5” and “fibroblast growth factor 5” found no passage linking that locus to a cardiovascular condition in a previous GWAS; the claim therefore cannot be verified from our copy. (LLM, conf=0.73)

    Experimental — accuracy not yet measured
  • The study detected a cis signal for the FGF5 level and associated variants in the region, which overlapped with previous GWAS findings for cardiovascular diseases and medications used to treat them.

    “We detected a cis signal for the FGF5 level and associated variants in the region, which overlapped with previous GWAS findings for cardiovascular diseases and medications used to treat them.”

    From Genetic determinants of plasma protein levels in the Estonian population (2024) · cites this paper as [75]

    The Scanning for additive associations section reports CAD-associated variants, and the Discussion mentions drugs used to lower CAD risk. Neither identifies an FGF5-region signal or shows that its variants overlap GWAS findings for cardiovascular disease or its medications. Searches for FGF5 and the claimed medication overlap found no passage addressing that specific point; page numbers were unavailable in our copy. (LLM, conf=0.74)

    Experimental — accuracy not yet measured
  • Numerous epidemiological studies, Mendelian randomization studies, and randomized controlled trials consistently show a log-linear relationship between absolute changes in plasma LDL-C and atherosclerotic cardiovascular disease risk.

    “Numerous epidemiological studies, Mendelian randomization studies, and RCTs have consistently demonstrated a log-linear relationship between the absolute changes in plasma LDL-C and the risk of ASCVD [34,45-50].”
  • Genomewide association analyses since 2007 have identified more than 50 independent loci associated with coronary artery disease risk.

    “Since 2007, genomewide association analyses have identified more than 50 independent loci associated with the risk of coronary artery disease.7–15”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
the CARDIoGRAMplusC4D Consortium
Venue
Nature Genetics
Published
2015-09-07
Volume
47
Issue
10
Pages
1121-1130
ISSN
  • 1061-4036 (ISSN-L)
  • 1546-1718
OpenAlex
W2238851414
Cited by
2,447
References
84
Citations by year
2026: 98 · 2025: 178 · 2024: 259 · 2023: 263 · 2022: 336 · 2021: 277 · 2020: 255 · 2019: 239 · 2018: 243 · 2017: 181 · 2016: 115 · 2015: 2 · 2014: 1
FWCI
22.88
Type
journal article
Language
en
Open access
Locations
  • Nature Genetics (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Site cant be reached (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Leiden Repository (Leiden University) (submittedVersion)
  • Discovery Research Portal (University of Dundee) (submittedVersion, other-oa)
  • Leicester Research Archive (University of Leicester) (submittedVersion, other-oa)
  • Lund University Publications (Lund University) (submittedVersion)
  • mediaTUM (Technical University of Munich) (submittedVersion)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
  • PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
  • Queen Mary Research Online (Queen Mary University of London) (submittedVersion)
  • Spiral (Imperial College London) (submittedVersion)
  • STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
Funders
  • Donald W. Reynolds Foundation
  • Amgen
  • School of Medicine, Boston University
  • Foundation for Cardiovascular Research
  • University of Oklahoma
  • Wellcome Trust
  • National Institute for Health and Care Research (NF-SI-0512-10165, NF-SI-0611-10170, HHSN268200625226C, NF-SI-0508-10235)
  • British Heart Foundation (FS/14/55/30806, QLG2-CT-2002-01254, RE/13/1/30181, RG/08/014/24067, RG/14/5/30893)
  • European Commission (QLG2-CT-2002-01254, 213506, 01254)
  • National Natural Science Foundation of China (81370002)
  • ZonMw (050-060-810)
  • Erasmus Universiteit Rotterdam
  • Erasmus Medisch Centrum (014-93-015)
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek (050.060.810, 916.12.154, 911-03-012, 175.010.2005.011)
  • Hjärt-Lungfonden (20120197)
  • Knut och Alice Wallenbergs Stiftelse
  • Vetenskapsrådet (2009-02298, 2012-01397, M-2005-1112)
  • Sydäntutkimussäätiö
  • Hjartavernd (HHSN271201200022C, N01-AG-1-2100)
  • Nestec
  • National Institutes of Health (HHSN268201100012C, HHSN271201200022C, HHSN268201100008C, HHSN268201100006C, N01-AG-1-2100, DK U01-066134, HHSN26820- 1100005C, HHSN268201100007C, HHSN268201100011C, EU/QLRT-2001-01254, HHSN268201100010C, HHSN268201100009C, HHSN268200625226C, HL-043851)
  • University of Oklahoma Health Sciences Center
  • Medical Research Council (MR/L01629X/1, MR/L003120/1)
  • Uppsala Multidisciplinary Center for Advanced Computational Science
  • National Heart, Lung, and Blood Institute (HHSN268201 100012C, R01HL080467, R01HL127564, HHSN268201100007C, HHSN2682 01100008C, HL043851, HH-SN-268201100006C, HHSN268201100011C, HL099355, R01 HL-59367, HHSN268201100005C, HHSN268201100010C, HHSN268200625226C, R01HL087641, R01HL059367, HHSN26820 1100009C, RC1HL099355, HL080467, R33HL120757, CA047988, R01HL117078, R01HL086694)
  • National Human Genome Research Institute (U01HG004402)
  • National Cancer Institute (HL-080467, HL-099355, HL-043851, CA 047988, UM1CA182913, R01CA047988)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK089256, R01DK082766, R01DK107437, NOT-HG-11-009)
  • National Center for Research Resources (UL1RR025005)
  • NHLBI Division of Intramural Research
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Mapping and Diversity in Plants and Animals
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Physical Performance
Keywords
coronary artery disease, genetic susceptibility, genetic susceptibility loci, single nucleotide polymorphisms, low-frequency variants, phased haplotypes, allelic heterogeneity, genetic architecture
MeSH terms
Coronary Artery Disease, Humans, Phenotype, Genome, Human, Genome-Wide Association Study

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review